Nizia Bakhshi, the founder and CEO of the Nizie Project, announced the start of the first project in a new collaboration with the Institute of Animal Cells, a collaboration led by the University of Pennsylvania.
The project will focus on the study of cell proliferation and differentiation and the development of methods to evaluate their potential applications.
Nizi, who was born with a condition that prevents her from producing eggs, was diagnosed with multiple sclerosis and is currently undergoing treatment.
She also has a rare form of leukaemia.
Nizis disease is caused by a genetic mutation that prevents the body from making enough proteins for her immune system to properly attack infections.
Her condition has made her unable to conceive or carry a pregnancy.
The Nizisi Project will help study the effect of differentiating cells in her body.
The Niziris Project will focus primarily on the role of the cells in the body’s own defense against infection.
It will also look at ways to treat disease, including cancer and autoimmune diseases, by removing harmful or abnormal cells.
Bakhshi told Bleacher Reports that she and the Institute will continue to research the potential benefits of the research.
“This is a great example of an intersection of research and innovation,” she said.
“The Institute of Animals is the leader in this area, and they’ve shown their commitment to the work of Niziya.”
The project, which will focus mainly on Nizira cells, is being funded by the National Institutes of Health and the National Science Foundation.
The first step in the project is to develop a cell-based imaging system that will use a combination of light and sound to analyze cells and their properties.
A prototype of the system will be developed and tested in a lab.
The study will include four different types of cells: normal, leukaemic, diabetic, and neuropathic.
Each type of cell has different characteristics and the researchers hope to identify which cells are most susceptible to the conditions that affect them.
Nazie Project scientists are using different types and types of technology to understand and treat different types, including leukaemias, diabetes, and cancer.
Nuzia is currently working with the National Institute of Diabetes and Digestive and Kidney Diseases, the University at Buffalo and the University in Pennsylvania to understand how differentiating different types can improve the immune response to disease.
The goal is to have the first prototype of a system by the end of the year.NIZI has been collaborating with the institute since 2007 and the institute is currently studying Nizicovirus, a virus that has been found in animals and humans.
NIZI hopes to see the treatment of NIZIs disease first.
“We want to learn as much as possible about Nizias disease, but also about how it’s treated,” Bakhshi said.